Commercial Hylenex® recombinant (hyaluronidase human injection)
Halo-117-403
Approved small_molecule completed
Quick answer
Commercial Hylenex® recombinant (hyaluronidase human injection) for Type 1 Diabetes Mellitus is a Approved program (small_molecule) at HALOZYME THERAPEUTICS, INC. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- HALOZYME THERAPEUTICS, INC.
- Indication
- Type 1 Diabetes Mellitus
- Phase
- Approved
- Modality
- small_molecule
- Status
- completed